As of 2025-12-29, the Relative Valuation of Harvard Bioscience Inc (HBIO) is (35.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Harvard Bioscience Inc based on Relative Valuation is -5206.9%.
The range of the Relative Valuation is (35.58) - (36.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.5x - 32.6x | 30.1x |
| Forward P/E multiples | 28.4x - 30.5x | 29.3x |
| Fair Price | (35.58) - (36.83) | (35.87) |
| Upside | -5165.6% - -5344.5% | -5206.9% |
| Date | P/E |
| 2025-12-26 | -0.58 |
| 2025-12-24 | -0.60 |
| 2025-12-23 | -0.60 |
| 2025-12-22 | -0.62 |
| 2025-12-19 | -0.62 |
| 2025-12-18 | -0.64 |
| 2025-12-17 | -0.65 |
| 2025-12-16 | -0.58 |
| 2025-12-15 | -0.58 |
| 2025-12-12 | -0.61 |
| 2025-12-11 | -0.62 |
| 2025-12-10 | -0.63 |
| 2025-12-09 | -0.60 |
| 2025-12-08 | -0.63 |
| 2025-12-05 | -0.63 |
| 2025-12-04 | -0.60 |
| 2025-12-03 | -0.60 |
| 2025-12-02 | -0.60 |
| 2025-12-01 | -0.63 |
| 2025-11-28 | -0.63 |
| 2025-11-26 | -0.62 |
| 2025-11-25 | -0.61 |
| 2025-11-24 | -0.53 |
| 2025-11-21 | -0.53 |
| 2025-11-20 | -0.47 |
| 2025-11-19 | -0.51 |
| 2025-11-18 | -0.53 |
| 2025-11-17 | -0.55 |
| 2025-11-14 | -0.55 |
| 2025-11-13 | -0.48 |
| 2025-11-12 | -0.52 |
| 2025-11-11 | -0.50 |
| 2025-11-10 | -0.48 |
| 2025-11-07 | -0.45 |
| 2025-11-06 | -0.45 |
| 2025-11-05 | -0.49 |
| 2025-11-04 | -0.51 |
| 2025-11-03 | -0.48 |
| 2025-10-31 | -0.43 |
| 2025-10-30 | -0.52 |
| 2025-10-29 | -0.37 |
| 2025-10-28 | -0.33 |
| 2025-10-27 | -0.33 |
| 2025-10-24 | -0.34 |
| 2025-10-23 | -0.33 |
| 2025-10-22 | -0.33 |
| 2025-10-21 | -0.34 |
| 2025-10-20 | -0.33 |
| 2025-10-17 | -0.31 |
| 2025-10-16 | -0.33 |